AI improves wound care at LUMC
The LUMC is collaborating with KickstartAI to develop a new AI model that assists nurses in creating wound reports. The model can generate a wound report based on photographs of the wound.
7 to 12 of 137 results
Prototype prevents brain damage and reduces workload at LUMC
The LUMC has developed a device for babies in the NICU who experience apnoea. Apnoea is a brief interruption in breathing, which can have dangerous consequences such as brain damage.
New antibiotic prevents bacteria from returning
A research group at the Leiden Institute of Biology (IBL) has developed a new antibiotic against the pathogenic intestinal bacterium Clostridioides difficile.
Pharmaceutical company Eli Lilly is constructing a new factory in Katwijk.
Eli Lilly, one of the largest pharmaceutical companies in the world, is setting up a new factory in Katwijk, close to Leiden Bio Science Park. It is estimated that the factory will create 500 jobs for the region.
The new future with AI
AI is developing rapidly and is influencing virtually all aspects of our society, such as research and education. However, these developments also entail risks.
Europe better prepared for pandemics
The biotech company Leyden Labs from Leiden has received an investment of €30 million for their new medicine, the PanFlu nasal spray. The nasal spray offers protection against flu viruses by leaving antibodies in the nose.